Literature DB >> 1408764

Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.

E Bonfils1, C Depierreux, P Midoux, N T Thuong, M Monsigny, A C Roche.   

Abstract

Inhibition of gene expression by antisense oligonucleotides is limited by their low ability to enter cells. Knowing that sugar binding receptors, also called membrane lectins, efficiently internalize neoglycoproteins bearing the relevant sugar, 6-phosphomannose, for instance, oligonucleotides--substituted on their 5'-end with either a fluorescent probe or a radioactive label on the one hand, and bearing a thiol function on their 3'-end, on the other hand,--were coupled onto 6-phosphomannosylated proteins via a disulfide bridge. The oligonucleotide bound to 6-phosphomannosylated serum albumin is much more efficiently internalized roughly 20 times than the free oligonucleotide. Although most of the oligonucleotides are associated with vesicular compartments, oligonucleotides after releasing from the carrier by reduction of the disulfide bridge may find their way to reach the cytosol and then lead to an increase in the efficiency of the oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1408764      PMCID: PMC334193          DOI: 10.1093/nar/20.17.4621

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  54 in total

1.  Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes.

Authors:  E P Feener; W C Shen; H J Ryser
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

2.  Generation of macrophage variants with 5-azacytidine: selection for mannose receptor expression.

Authors:  S Diment; M S Leech; P D Stahl
Journal:  J Leukoc Biol       Date:  1987-11       Impact factor: 4.962

3.  Drug targeting: anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine.

Authors:  P Midoux; E Negre; A C Roche; R Mayer; M Monsigny; J Balzarini; E De Clercq; E Mayer; A Ghaffar; J D Gangemi
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

4.  Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates.

Authors:  R G Shea; J C Marsters; N Bischofberger
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

5.  Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

Authors:  L A Yakubov; E A Deeva; V F Zarytova; E M Ivanova; A S Ryte; L V Yurchenko; V V Vlassov
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Characterization of oligonucleotide transport into living cells.

Authors:  S L Loke; C A Stein; X H Zhang; K Mori; M Nakanishi; C Subasinghe; J S Cohen; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein.

Authors:  W M Pardridge; R J Boado
Journal:  FEBS Lett       Date:  1991-08-19       Impact factor: 4.124

8.  Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.

Authors:  R L Letsinger; G R Zhang; D K Sun; T Ikeuchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation.

Authors:  D T Connolly; R R Townsend; K Kawaguchi; W R Bell; Y C Lee
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

10.  Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis.

Authors:  P Chakraborty; A N Bhaduri; P K Das
Journal:  Biochem Biophys Res Commun       Date:  1990-01-15       Impact factor: 3.575

View more
  6 in total

1.  Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides.

Authors:  C Pichon; M B Roufaï; M Monsigny; P Midoux
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.

Authors:  E A Biessen; H Vietsch; E T Rump; K Fluiter; J Kuiper; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

Review 3.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

4.  Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats.

Authors:  Zhaoyang Ye; Kun Cheng; Ramareddy V Guntaka; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

Review 5.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

6.  Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells.

Authors:  P Midoux; C Mendes; A Legrand; J Raimond; R Mayer; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.